Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
Cathepsin L-mediated EGFR cleavage affects intracellular signalling pathways in cancer
ID
Grozdanić, Marija
(
Author
),
ID
Sobotič, Barbara
(
Author
),
ID
Biasizzo, Monika
(
Author
),
ID
Sever, Tilen
(
Author
),
ID
Vidmar, Robert
(
Author
),
ID
Vizovišek, Matej
(
Author
),
ID
Turk, Boris
(
Author
),
ID
Fonović, Marko
(
Author
)
PDF - Presentation file,
Download
(4,88 MB)
MD5: 7D87F8EC9F49CB6F6B1FC5F06A622069
URL - Source URL, Visit
https://www.degruyter.com/document/doi/10.1515/hsz-2023-0213/html
Image galllery
Abstract
Proteolytic activity in the tumour microenvironment is an important factor in cancer development since it can also affect intracellular signalling pathways via positive feedback loops that result in either increased tumour growth or resistance to anticancer mechanisms. In this study, we demonstrated extracellular cathepsin L-mediated cleavage of epidermal growth factor receptor (EGFR) and identified the cleavage site in the extracellular domain after R224. To further evaluate the relevance of this cleavage, we cloned and expressed a truncated version of EGFR, starting at G225, in HeLa cells. We confirmed the constitutive activation of the truncated protein in the absence of ligand binding and determined possible changes in intracellular signalling. Furthermore, we determined the effect of truncated EGFR protein expression on HeLa cell viability and response to the EGFR inhibitors, tyrosine kinase inhibitor (TKI) erlotinib and monoclonal antibody (mAb) cetuximab. Our data reveal the nuclear localization and phosphorylation of EGFR and signal transducer and activator of transcription 3 (STAT3) in cells that express the truncated EGFR protein and suggest that these phenomena cause resistance to EGFR inhibitors.
Language:
English
Keywords:
cancer
,
cysteine cathepsin
,
cathepsin L
,
EGFR
,
extracellular cleavage
,
resistance to TKIs
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
FKKT - Faculty of Chemistry and Chemical Technology
Publication status:
Published
Publication version:
Version of Record
Year:
2024
Number of pages:
Str. 283–296
Numbering:
Vol. 405, iss. 4
PID:
20.500.12556/RUL-155448
UDC:
577.2
ISSN on article:
1431-6730
DOI:
10.1515/hsz-2023-0213
COBISS.SI-ID:
171358723
Publication date in RUL:
02.04.2024
Views:
359
Downloads:
90
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Biological chemistry
Shortened title:
Biol. chem.
Publisher:
De Gruyter
ISSN:
1431-6730
COBISS.SI-ID:
1541908
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Projects
Funder:
ARRS - Slovenian Research Agency
Project number:
P1-0140
Name:
Proteoliza in njena regulacija pri zdravju in boleznih
Funder:
ARRS - Slovenian Research Agency
Project number:
J1-1710
Name:
Vloga cisteinskih katepsinov pri aktivaciji komplementa pri raku
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back